Literature DB >> 485746

Retinal arteriolar changes as an indicator of coronary artery disease.

E L Michelson, J Morganroth, C W Nichols, H MacVaugh.   

Abstract

Funduscopic examination was performed in 70 non diabetic, nonhypertensive patients without valvular heart disease undergoing coronary angiography for evaluation of chest pain syndromes to determine if retinal arteriolar changes could reliably predict presence of coronary artery disease. Retinal arteriolar changes were graded with respect to light reflex, vessel caliber, arteriovenous crossing defects, and vessel tortuosity without knowledge of angiographic findings. Each coronary vessel was graded with respect to its most occlusive lesion by angiography; coronary index was derived for each patient without knowledge of eye findings. Abnormal light reflex changes were the most sensitive indicators of presence and extent of coronary artery disease. Abnormal vessel tortuosity and decreased caliber were less sensitive but more specific; their presence also suggested more extensive coronary lesions. Thus, funduscopic examination demonstrating specific retinal arteriolar lesions may indicate presence of coronary artery disease and may correlate with extent of lesions in selected patients.

Entities:  

Mesh:

Year:  1979        PMID: 485746

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

Review 1.  The relationship between retinal microvascular abnormalities and coronary heart disease: a review.

Authors:  Benjamin R McClintic; Jedediah I McClintic; John D Bisognano; Robert C Block
Journal:  Am J Med       Date:  2010-04       Impact factor: 4.965

2.  Retinal arteriolar tortuosity and cardiovascular risk factors in a multi-ethnic population study of 10-year-old children; the Child Heart and Health Study in England (CHASE).

Authors:  Christopher G Owen; Alicja R Rudnicka; Claire M Nightingale; Robert Mullen; Sarah A Barman; Naveed Sattar; Derek G Cook; Peter H Whincup
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-09       Impact factor: 8.311

3.  Hypertensive retinopathy and incident coronary heart disease in high risk men.

Authors:  B B Duncan; T Y Wong; H A Tyroler; C E Davis; F D Fuchs
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

4.  Retinal vessel diameter and the incidence of coronary artery disease in type 1 diabetes.

Authors:  Rachel G Miller; Catherine T Prince; Ronald Klein; Trevor J Orchard
Journal:  Am J Ophthalmol       Date:  2009-01-18       Impact factor: 5.258

Review 5.  Hypertensive eye disease.

Authors:  Carol Y Cheung; Valérie Biousse; Pearse A Keane; Ernesto L Schiffrin; Tien Y Wong
Journal:  Nat Rev Dis Primers       Date:  2022-03-10       Impact factor: 52.329

6.  Comparison of intima-media thickness and ophthalmic artery resistance index for assessing subclinical atherosclerosis in HIV-1-infected patients.

Authors:  Pierfrancesco Grima; Marcello Guido; Roberto Chiavaroli; Antonella De Donno; Mariangela Tana; Antonella Zizza
Journal:  Cardiovasc Ultrasound       Date:  2011-04-01       Impact factor: 2.062

7.  Retinal artery lesions and long-term outcome in Chinese patients with acute coronary syndrome.

Authors:  J Wang; M Zhao; S-J Li; D-Z Wang
Journal:  Eye (Lond)       Date:  2015-03-06       Impact factor: 3.775

8.  Usefulness of the Doppler flow of the ophthalmic artery in the evaluation of carotid and coronary atherosclerosis.

Authors:  Seung Pyo Hong; Yon Woong Park; Chan Wook Lee; Joung Won Park; Kyung Ryun Bae; Seung Woon Jun; Young Soo Lee; Jin Bae Lee; Jae Kean Ryu; Ji Yong Choi; Sung Guk Chang; Kee Sik Kim
Journal:  Korean Circ J       Date:  2014-11-25       Impact factor: 3.243

Review 9.  The eye and the heart.

Authors:  Josef Flammer; Katarzyna Konieczka; Rosa M Bruno; Agostino Virdis; Andreas J Flammer; Stefano Taddei
Journal:  Eur Heart J       Date:  2013-02-10       Impact factor: 29.983

10.  The clinical assessment of retinal microvascular structure and therapeutic implications.

Authors:  Alun D Hughes
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.